Jessica A. Kahn, M.D., M.P.H.

Jessica Kahn, MD MPH is professor of Pediatrics and Dr. Ernest Baden Chair in Head and Neck Pathology at Albert Einstein College of Medicine. She serves as Senior Associate Dean for Clinical and Translational Research and as Director of the Block Institute for Clinical and Translational Research (ICTR) at Albert Einstein College of Medicine.

Dr. Kahn received an MD from Harvard Medical School and MPH from the Harvard School of Public Health. She completed a residency in Pediatrics and fellowship in Adolescent Medicine at Boston Children’s Hospital then joined Cincinnati Children’s and the University of Cincinnati College of Medicine. At Cincinnati Children’s, she served as the Associate Chair of Academic Affairs and Career Development and as the Rauh Chair and Director of the Division of Adolescent and Transition Medicine. She also served as director of the KL2 Scholars Program and co-director of the Center for Clinical and Translational Science and Training, the University of Cincinnati’s Clinical and Translational Science Award. Her clinical practice focused on young women’s health, mental health disorders, and chronic conditions in adolescents and young adults. She joined Albert Einstein College of Medicine in 2024 to serve in the Dean’s office and as director of the ICTR, Montefiore Einstein’s Clinical and Translational Science Award.

Dr. Kahn is a clinical investigator whose long-term research objective is to reduce morbidity and mortality due to cervical cancer and other diseases related to human papillomavirus (HPV). Her research program focuses on primary and secondary prevention of HPV-related diseases through technologies such as Pap testing, HPV DNA testing, and HPV vaccines. Studies have characterized attitudes about HPV vaccination among adolescents, parents, and clinicians; predictors of clinician recommendations and adolescent uptake of HPV vaccines; epidemiology and risk factors for HPV in adolescents; acceptability and accuracy of HPV DNA self-testing in adolescents; impact of HPV vaccination on sexual attitudes and behaviors; immunogenicity and safety of HPV vaccines in young women and men living with HIV; the epidemiologic impact of HPV vaccine introduction in communities; and the use of technologies to improve HPV vaccine uptake. Her research has been funded by the NIH for almost 25 years and by the World Health Organization, foundations, and industry. Her work has resulted in more than 200 publications. She has served on leadership groups for the U01-funded Adolescent Medicine Trials Network for HIV/AIDS Interventions, as PI of a grant program that funded U.S. projects designed to improve adolescent vaccination, and as facilitator of a global HPV vaccine community of practice funded by the World Health Organization.

She has served on a number of national and international committees, including as President and Chief Executive Officer of the Society for Adolescent Health and Medicine, as a consultant for the National Academy of Sciences, on the National Vaccine Advisory Committee’s HPV Working Group, on CDC Advisory Committee on Immunization Practices working groups, on the World Health Organization’s HPV Vaccine Advisory Committee, and as chair of the International Pediatric Association’s HPV vaccine subgroup. She is an elected member of the Academic Pediatric Society and received the Society for Adolescent Health and Medicine’s Outstanding Achievement in Adolescent Health and Medicine award in 2024.

1. Kahn JA, Xu J, Kapogiannis B, Gonin R, Rudy B, Wilson C, Liu N, Worrell C, Squires K. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis. 2013;57(5):735-744. PMID: 23667266. PMCID: PMC3739463.
2. Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Millison ML. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth. Sex Transm Dis. 2015;42(5):246-252. PMCID: PMC4396681.
3. Kahn JA, Xu J, Kapogiannis BG, Sleasman JW. Antibody responses to quadrivalent HPV vaccination in HIV-infected young women as measured by total IgG and competitive Luminex immunoassay. J Acquir Immune Defic Syndr. 2017;75(2):241-245. PMCID: PMC5429191.
4. Rosen BL, Gorbach P, Ding L, Covert C, Ermel AC, Chandler E, Malagón T, Kahn JA. Sexual network patterns and their association with genital and anal human papillomavirus infection in adolescent and young men. Journal of Adolescent Health Aug 2020; 29:S1054-139X.
5. Hackworth JM, Meinzen-Derr J, DePalma M, Hostetter M, Klein M, O’Toole JK, Kahn JA. The Impact of Primary Mentors and Career Development Committees on Junior Faculty Productivity in a Pediatric Academic Health Center. Journal of Pediatrics Oct 2020; DOI:https://doi.org/10.1016/j.jpeds.2020.10.037.
6. Reed JL, Alessandrini E, Dexheimer J, Kachelmeyer A, Macaluso M, Nanhua Zhang, Kahn J. Effectiveness of a universally offered Chlamydia and gonorrhea screening intervention in the pediatric emergency department. Journal of Adolescent Health January 2021;68:57-64.
7. Rosen BL, Real FJ, Bishop JM, McDonald SL, Klein M, Kahn JA, Kreps GL. School health service provider perceptions on facilitated interactive role-play around HPV vaccine recommendations. Journal of Cancer Education Jan 2021; doi: 10.1007/s13187-020-01949-1.
8. Real J, Rosen, B, Bishop J, McDonald S, DeBlasio D, Klein M, Kahn JA. Usability Evaluation of the Novel Smartphone Application, HPV Vaccine: Same Way, Same DayTM, Among Pediatric Residents. Academic Pediatrics May-June 2021; 21:742-749.
9. Palefsky JM, Lensing S, Belzer M, Chi Z, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME, Chiao EY, Rierden D, Goldstone SE, Ortiz Martinez AP, Cachay ER, Barroso LF, Da Costa M, Wilson CM, Kahn JA for the AIDS Malignancy Consortium and Adolescent Medicine Trials Network for HIV/AIDS Interventions. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Clinical Infectious Diseases 2021;73:1388-1396. PMCID:PMC8528397.
10. Bishop JM, Real FJ, McDonald SL, Klein M, DeBlasio D, Kahn JA, Kreps GL, Rosen BL. Evaluation of HPV Vaccine: Same Way, Same DayTM: A pilot study. Journal of Health Communication January 2022; doi 10.1080/10810730.2021.2021459 PMID: 34985403.
11. Kahn JA, Washington C, Ding L, Wyllie T, Rosen B, Gorbach P. Partner-level and sexual networking factors are associated with vaccine-type and non-vaccine-type human papillomavirus infection after vaccine introduction in young women. Sexually Transmitted Diseases; June 2022; 49:429-436. PMCID: PMC9133057.
12. Morales-Campos DY, Flores BE, Donovan E, Burdick S, Parra-Medina D, Kahn JA. A qualitative descriptive study of providers’ perspectives on human papillomavirus vaccine administration among Latino adolescents in South Texas clinics: barriers and facilitators. BMC Public Health 2022; doi: 10.1186/s12889-022-12837-2
13. Real FJ, Ollberding NJ, Meisman A, DeBlasio D, Pero MB, Davis D, Cruse B, Klein M, Kahn JA, Rosen BL. Impact of a Virtual Reality Curriculum on Human Papillomavirus Vaccination: A Pilot Trial. Am J Prev Med. 2022;63(5):865-873. PMID: 35778065. PMCID: PMC9639394.
14. Real FJ, Meisman A, Fleck L, Klein M, Kahn JA, Rosen B. Evolution of education focused digital interventions to support HPV vaccination. Academic Pediatrics 2024; 24:559-551. PMID: 37952877.
15. Kim M, Kim E, Lee H, Piao M, Rosen B, Allison J, Zai A, Nguyen H, Shin DS, Kahn JA. A Culturally Tailored AI Chatbot (K-Bot) to Promote HPV Vaccination Among Korean Americans: Development and Usability Study. Asian Pac Isl Nurs J April 2025; doi: 10.2196/71865. PMID 40194281.
16. Morales-Campos DY, Adsul P, Liang Y, Donovan E, Moczygemba LR, Kahn JA. Trusted Health System Implementation Strategies to increase vaccination (TRUE SYNERGI): A stepped-wedge cluster randomized trial to reduce HPV-related cancers. BMC Public Health April 2025; 25:1331. PMID: 40205591
17. Fishman AY, Lounsbury DW, Lechuga C, Kahn J, Kim M, Keller MJ. Evaluation means Making CQI Collaborative (E = MC2): Lessons learned from implementing a new Continuous Quality Improvement process at our Montefiore-Einstein hub. JCTS August 2025; 27:e201. PMID: 41069350 PMCID: PMC12505234
18. DeSieghardt A, Ermel A, Franco EL, Dagnall C, Brown D, Yao S, Kahn JA. Real-World Effectiveness and Herd Protection 17 Years After Human Papillomavirus Vaccine Introduction. JAMA Pediatrics September 2025; doi: 10.1001/jamapediatrics.2025.3568.
19. Kahn JA, Kowalczyk Mullins, TL. Attitudes Toward and Preferences for Different Routes of Delivery of HIV Pre-Exposure Prophylaxis (PrEP) Among Young Transgender Men and Transmasculine People. Journal of Adolescent Health September 2025; 77:565-572. PMID: 40704955.
20. Rosen B.L., Lee M., Chandler E., Meisman, A., Kahn J., Klein M., Real F.J. Factors influencing adolescent COVID-19 vaccination during the Omicron surge. Health Promotion Practice January 2026; 27:36-41. PMID: 39834335